Financial Data and Key Metrics Changes - Total revenues for Q1 2025 were $440.8 million, a 12% decrease from $500.2 million a year ago [12] - Overall gross margin decreased by 2.7 percentage points to 28.4% [12] - Adjusted EBITDA for the quarter was $54 million, down from $64 million last year [12] - Net income for the quarter was $32.8 million, compared to $41.4 million a year ago [12] - GAAP earnings per share were $1.31, down from $1.65 a year ago [12] Business Line Data and Key Metrics Changes - **Performance Chemicals**: Revenues were $168.4 million, up 5% from $160.8 million last year, with operating income of $19.8 million, down 6% [13] - **Fuel Specialties**: Revenues were £170.3 million, down 4% from £176.9 million, but operating income increased by 10% to $36.9 million [14] - **Oilfield Services**: Revenues were $102.1 million, a 37% decrease from $162.5 million, with operating income down 76% to $4.1 million [15] Market Data and Key Metrics Changes - Performance Chemicals experienced a volume growth of 5% but faced a negative currency impact of 3% [13] - Fuel Specialties faced a 2% adverse price mix and a negative currency impact of 2% [14] - Oilfield Services saw no sales in Latin America, impacting overall performance [15] Company Strategy and Development Direction - The company remains focused on delivering full-year operating income growth and margin improvement despite near-term challenges [7] - There is a commitment to security of supply, innovation, and world-class customer service [17] - The company is positioned for growth and margin expansion as market conditions recover, with a strong debt-free balance sheet allowing for flexibility in capital deployment [18] Management's Comments on Operating Environment and Future Outlook - Management noted that market conditions are extremely volatile, which may hinder the 2025 target for sequential improvement in operating income [7] - There is cautious optimism regarding customer behavior and inventory management in the Performance Chemicals segment [6][36] - The company expects to see some stabilization in oilfield services as crude prices remain steady [63] Other Important Information - Cash from operating activities was $28.3 million before capital expenditures of $15.5 million [16] - The company bought back 34,100 shares at a cost of $3.3 million and had $299.8 million in cash and cash equivalents with no debt [16][19] - The Board approved a 10% increase in the semiannual dividend to $0.84 per share [19] Q&A Session Summary Question: Impact of tariffs on input costs and exports - Management indicated that they are monitoring the situation and have flexible supply chains to manage potential impacts [25][30] Question: Trends in Performance Chemicals and margin trajectory - Management noted that trends are influenced by customer inventory management and a mix of volume and pricing pressures [34][39] Question: Cost actions in the oilfield business - Cost initiatives include asset consolidation, personnel adjustments, and efficiency improvements [42] Question: Earnings cadence for the rest of the year - Management expects Q2 to be lower sequentially but anticipates improvement in the latter half of the year [44][48] Question: Stability of Fuel Specialties business - Management expressed confidence in the stability of the Fuel Specialties business despite external pressures [54] Question: R&D efforts and customer collaborations - There has been no change in customer collaboration or R&D efforts, with some projects potentially accelerating [72][73] Question: Capital deployment and share buyback strategy - The company plans to be opportunistic with share buybacks while maintaining flexibility for growth and M&A [84]

PART I [Condensed Consolidated Financial Statements](index=5&type=section&id=Item%201%20Condensed%20Consolidated%20Financial%20Statements) In Q1 2025, Innospec reported decreased net sales and net income, with a significant decline in operating cash flow, while total assets increased Condensed Consolidated Statements of Income (Q1 2025 vs Q1 2024) | Financial Metric | Q1 2025 (in millions) | Q1 2024 (in millions) | Change | | :--- | :--- | :--- | :--- | | **Net Sales** | $440.8 | $500.2 | -11.9% | | **Gross Profit** | $125.1 | $155.7 | -19.7% | | **Operating Income** | $42.5 | $50.5 | -15.8% | | **Net Income** | $32.8 | $41.4 | -20.8% | | **Diluted EPS** | $1.31 | $1.65 | -20.6% | Condensed Consolidated Balance Sheet Highlights | Balance Sheet Item | March 31, 2025 (in millions) | December 31, 2024 (in millions) | | :--- | :--- | :--- | | Cash and cash equivalents | $299.8 | $289.2 | | Total current assets | $977.1 | $956.6 | | Total assets | $1,774.6 | $1,734.7 | | Total current liabilities | $357.6 | $371.4 | | Total liabilities | $508.9 | $518.6 | | Total equity | $1,265.7 | $1,216.1 | Condensed Consolidated Statements of Cash Flows (Q1 2025 vs Q1 2024) | Cash Flow Activity | Q1 2025 (in millions) | Q1 2024 (in millions) | | :--- | :--- | :--- | | Net cash provided by operating activities | $28.3 | $80.6 | | Net cash used in investing activities | $(15.5) | $(14.3) | | Net cash provided by/(used in) financing activities | $(3.8) | $0.5 | | Net change in cash and cash equivalents | $10.6 | $66.4 | [Segment Reporting](index=10&type=section&id=NOTE%202%20%E2%80%93%20SEGMENT%20REPORTING) - The company operates through three reportable segments: Performance Chemicals, Fuel Specialties, and Oilfield Services, with performance evaluated by the CODM based on gross profit and operating income[28](index=28&type=chunk)[29](index=29&type=chunk) Segment Performance (Q1 2025 vs Q1 2024) | Segment | Net Sales (Q1 2025) | Net Sales (Q1 2024) | Operating Income (Q1 2025) | Operating Income (Q1 2024) | | :--- | :--- | :--- | :--- | :--- | | Performance Chemicals | $168.4M | $160.8M | $19.8M | $21.1M | | Fuel Specialties | $170.3M | $176.9M | $36.9M | $33.4M | | Oilfield Services | $102.1M | $162.5M | $4.1M | $16.9M | [Goodwill & Intangible Assets](index=12&type=section&id=NOTE%204%20%E2%80%93%20GOODWILL%20%26%20NOTE%205%20%E2%80%93%20OTHER%20INTANGIBLE%20ASSETS) - Goodwill increased to **$388.4 million** as of March 31, 2025, from **$382.5 million** at year-end 2024, with the change attributed to foreign exchange effects[34](index=34&type=chunk) - The company capitalized **$7.2 million** in Q1 2025 for internally developed software related to a new Enterprise Resource Planning (ERP) system, which is expected to be completed in 2026[36](index=36&type=chunk) [Long-Term Debt](index=14&type=section&id=NOTE%208%20%E2%80%93%20LONG-TERM%20DEBT) - As of March 31, 2025, the company had no outstanding borrowings on its **$250.0 million** multicurrency revolving credit facility, which is available until May 30, 2028[44](index=44&type=chunk) [Contingencies](index=16&type=section&id=NOTE%2012%20%E2%80%93%20CONTINGENCIES) - The company is pursuing a civil and criminal legal claim related to a misappropriation of inventory in Brazil, with no significant developments having occurred and no asset for potential recovery recorded[55](index=55&type=chunk) [Management's Discussion and Analysis (MD&A)](index=21&type=section&id=Item%202%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations%20for%20the%20Three%20Months%20Ended%20March%2031%2C%202025) The company experienced an overall decline in net sales and gross profit in Q1 2025, primarily driven by the Oilfield Services segment, while maintaining a strong liquidity position Overall Performance Summary (Q1 2025 vs Q1 2024) | Metric | Q1 2025 | Q1 2024 | Change | | :--- | :--- | :--- | :--- | | Net Sales | $440.8M | $500.2M | -12% | | Gross Profit | $125.1M | $155.7M | -20% | | Gross Margin | 28.4% | 31.1% | -2.7 p.p. | | Operating Income | $42.5M | $50.5M | -16% | [Results of Operations by Segment](index=21&type=section&id=Results%20of%20Operations) - **Performance Chemicals:** Net sales grew **5%** to **$168.4 million**, driven by an **11%** volume increase in the Americas and **31%** in ASPAC for personal care products, though gross margin decreased by **2.4 percentage points** to **21.0%** due to pricing pressure and an adverse product mix[75](index=75&type=chunk)[76](index=76&type=chunk) - **Fuel Specialties:** Net sales decreased **4%** to **$170.3 million**, with increased volumes in the Americas and EMEA offset by lower volumes in ASPAC and adverse price/mix effects, while gross margin improved by **1.4 percentage points** to **35.7%** due to a better sales mix and lower raw material costs[78](index=78&type=chunk)[79](index=79&type=chunk) - **Oilfield Services:** Net sales fell sharply by **37%** to **$102.1 million**, primarily due to significantly lower production chemical activity in Latin America, and gross margin contracted by **6.9 percentage points** to **28.4%** because of an unfavorable sales mix from weakened customer demand[80](index=80&type=chunk) - The adjusted effective tax rate was **24.4%** in Q1 2025, slightly down from **24.5%** in Q1 2024, mainly because a higher proportion of profits were generated in lower-tax jurisdictions[84](index=84&type=chunk)[85](index=85&type=chunk) [Liquidity and Financial Condition](index=26&type=section&id=Liquidity%20and%20Financial%20Condition) - Adjusted working capital increased by **$27.1 million** during the quarter, primarily driven by a **$14.4 million** increase in inventories to manage supply chain risks and prepare for planned maintenance[86](index=86&type=chunk)[87](index=87&type=chunk)[89](index=89&type=chunk) - Cash from operating activities decreased to **$28.3 million** in Q1 2025 from **$80.6 million** in Q1 2024, due to lower operating income and less favorable working capital cash flows, particularly from increased inventory levels[92](index=92&type=chunk) - The company ended the quarter with **$299.8 million** in cash and cash equivalents and no outstanding debt under its **$250.0 million** revolving credit facility[93](index=93&type=chunk)[95](index=95&type=chunk) [Quantitative and Qualitative Disclosures about Market Risk](index=28&type=section&id=Item%203%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) The company's market risk exposure, including interest rates, foreign currency, and commodity prices, remains consistent with its 2024 Form 10-K, utilizing derivatives for hedging purposes - There have been no significant changes in the Company's exposure to market risk since the 2024 Form 10-K[100](index=100&type=chunk) - The company uses derivatives, including foreign currency forward exchange contracts and commodity swaps, to manage market risks related to currency fluctuations and raw material costs[98](index=98&type=chunk)[99](index=99&type=chunk) [Controls and Procedures](index=29&type=section&id=Item%204%20Controls%20and%20Procedures) Management concluded that disclosure controls were effective as of March 31, 2025, with ongoing ERP system implementation and no material changes to internal controls over financial reporting - The CEO and CFO concluded that the Company's disclosure controls and procedures were effective as of March 31, 2025[101](index=101&type=chunk) - The company is continuing the implementation of a new ERP system and has updated its internal controls over financial reporting to accommodate the changes, with no material changes to internal controls reported in the quarter[103](index=103&type=chunk)[104](index=104&type=chunk) PART II [Legal Proceedings](index=30&type=section&id=Item%201%20Legal%20Proceedings) The company is involved in routine legal proceedings, including an ongoing civil and criminal claim in Brazil regarding inventory misappropriation, with no significant new developments - The company continues to pursue legal claims regarding a misappropriation of inventory in Brazil, with no significant new developments reported[107](index=107&type=chunk) [Risk Factors](index=30&type=section&id=Item%201A%20Risk%20Factors) No material changes in the company's risk factors have occurred since its 2024 Annual Report on Form 10-K filing - No material changes in risk factors have occurred since the company's 2024 Form 10-K filing[109](index=109&type=chunk) [Share Repurchases](index=30&type=section&id=Item%202%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company initiated a new **$50 million** stock repurchase program on March 10, 2025, repurchasing **48,050** shares during the quarter, with **$46.7 million** remaining available - A new stock repurchase program was announced on March 10, 2025, allowing for up to **$50 million** in common stock repurchases over a three-year period[111](index=111&type=chunk) Share Repurchases (Q1 2025) | Period | Total Shares Purchased | Average Price Paid | Value Remaining in Program | | :--- | :--- | :--- | :--- | | Feb 1 - Feb 28, 2025 | 1,227 | $105.1 | $50.0M (New program not yet started) | | Mar 1 - Mar 31, 2025 | 46,823 | $99.0 | $46.7M | | **Total** | **48,050** | **$99.1** | **$46.7M** |

Financial Performance Overview - Q1 2025 consolidated revenue decreased by 12 percent[12] - Q1 2025 gross margin decreased by 2.7 percentage points[12] - Q1 2025 operating income decreased by 16 percent[12] - Q1 2025 adjusted EBITDA decreased by 16 percent[12] - Q1 2025 adjusted EPS was $1.42[12] - The company has $299.8 million in net cash[6, 28] Segment Performance - Performance Chemicals revenue increased by 5 percent, with volumes up 5 percent and price/mix up 3 percent; operating income decreased by 6 percent[15] - Fuel Specialties revenue decreased by 4 percent, but operating income increased by 10 percent; gross margin increased by 1.4 percentage points[16, 18] - Oilfield Services revenue decreased by 37 percent, with operating income down 76 percent; gross margin decreased by 6.9 percentage points[19, 21] Corporate & Balance Sheet - Corporate costs decreased due to lower performance-related remuneration[25] - The effective tax rate was 26.1 percent[25] - Operating cash inflow was $28.3 million, with capital expenditures of $15.5 million[28]

[Q1 2025 Financial & Operational Highlights](index=1&type=section&id=INNOSPEC%20REPORTS%20FIRST%20QUARTER%202025%20FINANCIAL%20RESULTS) Innospec reported a 12% revenue decrease and 21% net income decline in Q1 2025, alongside strong cash generation and increased shareholder returns [Financial Performance Summary](index=1&type=section&id=Financial%20Performance%20Summary) In Q1 2025, Innospec reported a 12% revenue decrease to $440.8 million and a 21% net income decline to $32.8 million, with balanced segment performance Financial Performance Overview | Financial Metric | Q1 2025 | Q1 2024 | Change | | :--- | :--- | :--- | :--- | | Total Revenues | $440.8 million | $500.2 million | -12% | | Net Income | $32.8 million | $41.4 million | -21% | | GAAP Diluted EPS | $1.31 | $1.65 | -21% | | Adjusted non-GAAP EPS | $1.42 | $1.75 | -19% | | Adjusted EBITDA | $54.0 million | $64.0 million | -16% | - The quarter's results were balanced, with **strong Fuel Specialties growth** offsetting weaker Performance Chemicals and Oilfield Services performance[1](index=1&type=chunk)[6](index=6&type=chunk) [Cash Flow and Capital Allocation](index=1&type=section&id=Cash%20Flow%20and%20Capital%20Allocation) Innospec generated **$28.3 million** in operating cash flow, maintained a **debt-free balance sheet** with **$299.8 million net cash**, and enhanced shareholder returns through dividends and buybacks - Operating cash flow was **$28.3 million**, with the quarter ending in a **$299.8 million net cash position** and a **debt-free balance sheet**[1](index=1&type=chunk)[4](index=4&type=chunk)[13](index=13&type=chunk) - The semi-annual dividend increased by **10% to $0.84 per common share**[1](index=1&type=chunk)[2](index=2&type=chunk)[15](index=15&type=chunk) - A new **$50 million share buyback program** was initiated, with **34,100 shares repurchased for $3.3 million** during the quarter[1](index=1&type=chunk)[4](index=4&type=chunk)[15](index=15&type=chunk) [Management Commentary & Outlook](index=2&type=section&id=Management%20Commentary%20%26%20Outlook) Management noted a balanced quarter with strong Fuel Specialties performance offsetting other segments, anticipating delayed recovery in Performance Chemicals and Oilfield Services due to market volatility, while maintaining confidence in overall stability and strategic flexibility - **Performance Chemicals:** Initial momentum slowed due to customer caution regarding tariff announcements, delaying the return to 2022 operating income and margin levels[7](index=7&type=chunk) - **Fuel Specialties:** The segment achieved **double-digit operating income growth** driven by margin improvement, with a focus on full-year operating income growth[8](index=8&type=chunk) - **Oilfield Services:** Results were below expectations due to no recovery in Latin America and lower US activity, with no Latin American recovery anticipated next quarter[9](index=9&type=chunk) - **Overall Outlook:** Fuel Specialties is expected to remain stable, while sequential recovery in Performance Chemicals and Oilfield Services may be delayed by the economic environment, with the strong balance sheet supporting M&A, dividends, and buybacks[14](index=14&type=chunk)[15](index=15&type=chunk) [Segment Performance](index=2&type=section&id=Segment%20Performance) Q1 2025 segment performance was mixed, with Fuel Specialties achieving **10% operating income growth** despite revenue decline, while Performance Chemicals saw a **6% operating income drop** and Oilfield Services a **76% plunge** due to revenue decrease and weaker sales mix [Performance Chemicals](index=2&type=section&id=Performance%20Chemicals) Performance Chemicals revenues grew **5% to $168.4 million** driven by volume and price/mix, but a **2.4 percentage point gross margin decrease** led to a **6% decline in operating income to $19.8 million** Performance Chemicals Segment Metrics | Metric | Q1 2025 | Q1 2024 | Change | | :--- | :--- | :--- | :--- | | Revenues | $168.4 million | $160.8 million | +5% | | Gross Margin | 21.0% | 23.4% | -2.4 p.p. | | Operating Income | $19.8 million | $21.1 million | -6% | [Fuel Specialties](index=2&type=section&id=Fuel%20Specialties) Fuel Specialties revenues decreased **4% to $170.3 million**, yet operating income grew **10% to $36.9 million**, driven by a **1.4 percentage point increase in gross margin to 35.7%** Fuel Specialties Segment Metrics | Metric | Q1 2025 | Q1 2024 | Change | | :--- | :--- | :--- | :--- | | Revenues | $170.3 million | $176.9 million | -4% | | Gross Margin | 35.7% | 34.3% | +1.4 p.p. | | Operating Income | $36.9 million | $33.4 million | +10% | [Oilfield Services](index=2&type=section&id=Oilfield%20Services) Oilfield Services revenues fell **37% to $102.1 million**, with gross margins contracting **6.9 percentage points to 28.4%**, leading to a **76% decrease in operating income to $4.1 million** Oilfield Services Segment Metrics | Metric | Q1 2025 | Q1 2024 | Change | | :--- | :--- | :--- | :--- | | Revenues | $102.1 million | $162.5 million | -37% | | Gross Margin | 28.4% | 35.3% | -6.9 p.p. | | Operating Income | $4.1 million | $16.9 million | -76% | [Financial Statements](index=5&type=section&id=Financial%20Statements) This section presents the company's Q1 2025 consolidated income, balance sheet, cash flow statements, and segmental analysis, along with non-GAAP reconciliations [Condensed Consolidated Statements of Income](index=5&type=section&id=CONDENSED%20CONSOLIDATED%20STATEMENTS%20OF%20INCOME) This statement details the company's Q1 2025 income, showing a decline in net sales from **$500.2 million to $440.8 million** and net income from **$41.4 million to $32.8 million** Condensed Consolidated Statements of Income | (in millions, except per share data) | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 | | :--- | :--- | :--- | | **Net sales** | **$ 440.8** | **$ 500.2** | | Gross profit | 125.1 | 155.7 | | Operating income | 42.5 | 50.5 | | **Net income** | **$ 32.8** | **$ 41.4** | | **Diluted EPS** | **$ 1.31** | **$ 1.65** | [Segmental Analysis of Results](index=6&type=section&id=SEGMENTAL%20ANALYSIS%20OF%20RESULTS) This schedule provides a detailed breakdown of net sales and operating income for Performance Chemicals, Fuel Specialties, and Oilfield Services segments for Q1 2025 versus Q1 2024 Segmental Analysis of Results | (in millions) | Q1 2025 Net Sales | Q1 2024 Net Sales | Q1 2025 Operating Income | Q1 2024 Operating Income | | :--- | :--- | :--- | :--- | :--- | | Performance Chemicals | $ 168.4 | $ 160.8 | $ 19.8 | $ 21.1 | | Fuel Specialties | 170.3 | 176.9 | 36.9 | 33.4 | | Oilfield Services | 102.1 | 162.5 | 4.1 | 16.9 | | **Total** | **$ 440.8** | **$ 500.2** | **$ 43.1** | **$ 51.2** | [Reconciliation of Non-GAAP Measures (Adjusted EBITDA)](index=6&type=section&id=NON-GAAP%20MEASURES) This schedule reconciles GAAP Net Income to Adjusted EBITDA, showing Q1 2025 Net Income of **$32.8 million** reconciled to an Adjusted EBITDA of **$54.0 million** Reconciliation of Non-GAAP Measures (Adjusted EBITDA) | (in millions) | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 | | :--- | :--- | :--- | | Net income | $ 32.8 | $ 41.4 | | Interest income, net | (2.4) | (2.1) | | Income taxes | 11.6 | 13.9 | | Depreciation and amortization | 10.9 | 10.3 | | Other adjustments | 1.1 | 0.5 | | **Adjusted EBITDA** | **$ 54.0** | **$ 64.0** | [Condensed Consolidated Balance Sheets](index=7&type=section&id=CONDENSED%20CONSOLIDATED%20BALANCE%20SHEETS) This statement presents the company's financial position as of March 31, 2025, showing total assets increased to **$1,774.6 million** and a strong liquidity position with **$299.8 million in cash** and no debt Condensed Consolidated Balance Sheets | (in millions) | March 31, 2025 | December 31, 2024 | | :--- | :--- | :--- | | **Cash and cash equivalents** | **$ 299.8** | **$ 289.2** | | Total current assets | 977.1 | 956.6 | | **Total assets** | **$ 1,774.6** | **$ 1,734.7** | | Total current liabilities | 357.6 | 371.4 | | **Total liabilities** | **508.9** | **518.6** | | **Total equity** | **1,265.7** | **1,216.1** | [Condensed Consolidated Statements of Cash Flows](index=8&type=section&id=CONDENSED%20CONSOLIDATED%20STATEMENTS%20OF%20CASH%20FLOWS) This statement details Q1 2025 cash flows, showing **$28.3 million** from operations, **$15.5 million** used in investing, and a net cash increase of **$10.6 million** Condensed Consolidated Statements of Cash Flows | (in millions) | Three Months Ended March 31, 2025 | Three Months Ended March 31, 2024 | | :--- | :--- | :--- | | **Net cash provided by operating activities** | **$ 28.3** | **$ 80.6** | | Net cash used in investing activities | (15.5) | (14.3) | | Net cash (used in)/provided by financing activities | (3.8) | 0.5 | | **Net change in cash and cash equivalents** | **10.6** | **66.4** | | Cash and cash equivalents at end of period | $ 299.8 | $ 270.1 |

Company Performance - Innospec reported quarterly earnings of $1.42 per share, exceeding the Zacks Consensus Estimate of $1.40 per share, but down from $1.75 per share a year ago, indicating an earnings surprise of 1.43% [1] - The company posted revenues of $440.8 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 4.03%, and down from $500.2 million year-over-year [2] - Over the last four quarters, Innospec has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [2] Future Outlook - The sustainability of Innospec's stock price movement will depend on management's commentary during the earnings call and the company's earnings outlook [3][4] - The current consensus EPS estimate for the upcoming quarter is $1.38 on revenues of $460.45 million, and for the current fiscal year, it is $5.93 on revenues of $1.9 billion [7] - The estimate revisions trend for Innospec is currently favorable, resulting in a Zacks Rank 2 (Buy) for the stock, suggesting it is expected to outperform the market in the near future [6] Industry Context - The Chemical - Diversified industry, to which Innospec belongs, is currently in the bottom 18% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact investor decisions [5]

Core Insights - Innospec Inc. reported a balanced quarter with strong growth in Fuel Specialties offsetting declines in Performance Chemicals and Oilfield Services [2][8][10] - The company generated $28.3 million in cash from operations, leading to a net cash position of $299.8 million [2][5][14] - A 10% increase in the semi-annual dividend to $0.84 per share was announced, along with a $50 million share buyback program [3][14] Financial Performance - Total revenues for Q1 2025 were $440.8 million, down 12% from $500.2 million in Q1 2024 [4][21] - Net income for the quarter was $32.8 million, or $1.31 per diluted share, compared to $41.4 million, or $1.65 per diluted share, in the same period last year [4][21] - Adjusted EBITDA for the quarter was $54.0 million, down from $64.0 million a year ago [5][25] Segment Analysis - Performance Chemicals generated revenues of $168.4 million, a 5% increase year-over-year, but operating income decreased by 6% to $19.8 million [10][23] - Fuel Specialties reported revenues of $170.3 million, down 4% from the previous year, but operating income increased by 10% to $36.9 million [11][23] - Oilfield Services revenues fell 37% to $102.1 million, with operating income declining 76% to $4.1 million [12][23] Market Outlook - The company anticipates that uncertainty surrounding tariff policies will delay recovery in Performance Chemicals and Oilfield Services, while Fuel Specialties is expected to remain stable [8][13] - Despite current market conditions, the company is focused on growth and margin improvement across all business segments [10][14]

ENGLEWOOD, Colo., April 03, 2025 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced that it will release first quarter 2025 earnings results on Thursday, May 8, 2025 after market close. Following the release of its results, Patrick S. Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer, will host an interactive conference call on Friday, May 9, 2025, at 9:00 a.m. ET. The public is invited to listen to the conference call by r ...

Innospec Inc. (IOSP) recently announced that its board has approved a new $50 million share repurchase program. The company's earlier $50 million program expired in the first quarter of 2025.With more than $289 million in net cash, the company retains considerable flexibility and balance sheet strength for future M&A, organic investment, dividend growth and share repurchases under this renewed repurchase program.The company reported fourth-quarter adjusted earnings of $1.41 per share, which exceeded the Zac ...

Group 1 - Innospec Inc. has announced a new $50 million share repurchase program, following the expiration of its previous program in Q1 2025 [1] - The company has over $289 million in net cash, indicating strong balance sheet strength and flexibility for future mergers and acquisitions, organic investments, dividend growth, and share repurchases [1] - Share repurchases will be conducted at management's discretion [1] Group 2 - Innospec Inc. is an international specialty chemicals company with approximately 2,450 employees across 22 countries [2] - The company manufactures and supplies a diverse range of specialty chemicals for various markets, including Personal Care, Home Care, Agrochemical, Mining, and Industrial sectors [2] - Innospec's Fuel Specialties business focuses on fuel additives that enhance fuel efficiency, engine performance, and reduce harmful emissions [2] - The Oilfield Services segment provides specialty chemicals for the oil and gas exploration and production industry [2]

Group 1 - The article expresses a bullish outlook on Innospec's long-term prospects as a small specialty chemical company [1] - There are concerns regarding Innospec's exposure to increasingly turbulent end-markets [1]